Characterization of in vivo tumorigenicity tests using severe immunodeficient NOD/Shi-scid IL2Rγnull mice for detection of tumorigenic cellular impurities in human cell-processed therapeutic products-Reference-Cited by-同舟云学术

Characterization of in vivo tumorigenicity tests using severe immunodeficient NOD/Shi-scid IL2Rγnull mice for detection of tumorigenic cellular impurities in human cell-processed therapeutic products

Published:2015-06 Issue: Volume:1 Page:30-37
ISSN:2352-3204
Container-title:Regenerative Therapy
language:en
Short-container-title:Regenerative Therapy

Author:

Kusakawa Shinji,Machida Kazuhiko,Yasuda Satoshi,Takada Nozomi,Kuroda Takuya,Sawada Rumi,Okura Hanayuki,Tsutsumi Hideki,Kawamata Shin,Sato Yoji

Publisher

Elsevier BV

Subject

Developmental Biology,Biomedical Engineering,Biomaterials

Reference41 articles.

1. Requirements for the use of animal cells as in vitro substrates for the production of biologicals;World Health Organization,1998

2. Tumorigenicity studies for human pluripotent stem cell-derived products;Kuroda;Biological Pharm Bull,2013

3. Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain;Goldman;Br J Haematol,1998

4. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells;Ito;Blood,2002

5. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells;Shultz;J Immunol,2005

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protocol improvement and multisite validation of a digital soft agar colony formation assay for tumorigenic transformed cells intermingled in cell therapy products;Cytotherapy;2024-07

2. Differential modulation of cell morphology, migration, and Neuropilin-1 expression in cancer and non-cancer cell lines by substrate stiffness;Frontiers in Cell and Developmental Biology;2024-06-05

3. Advantages of pooling of human bone marrow-derived mesenchymal stromal cells from different donors versus single-donor MSCs;Scientific Reports;2024-06-02

4. Genetically Engineered CLDN18.2 CAR-T Cells Expressing Synthetic PD1/CD28 Fusion Receptors Produced Using a Lentiviral Vector;Journal of Microbiology;2024-05-03

5. Cancer Spheroids Embedded in Tissue-Engineered Skin Substitutes: A New Method to Study Tumorigenicity In Vivo;International Journal of Molecular Sciences;2024-01-26